Short-term treatment with rosiglitazone improves glucose tolerance, insulin sensitivity and endothelial function in renal transplant recipients.
about
New-onset diabetes mellitus after kidney transplantation: Current status and future directionsAssociation between insulin resistance and endothelial dysfunction in renal transplant recipients.Early exposure of the pregestational intrauterine and postnatal growth-restricted female offspring to a peroxisome proliferator-activated receptor-{gamma} agonist.Drug insight: thiazolidinediones and diabetic nephropathy--relevance to renoprotection.The peroxisome proliferator-activated receptor gamma agonist pioglitazone improves cardiometabolic risk and renal inflammation in murine lupus.Prevention and management of transplant-associated diabetes.Emerging treatments for post-transplantation diabetes mellitus.Insulin resistance and vascular dysfunction in chronic kidney disease: mechanisms and therapeutic interventions.Diabetes Mellitus Following Renal Transplantation: Clinical and Pharmacological Considerations for the Elderly Patient.Protective Actions of PPAR-gamma Activation in Renal Endothelium.Rosiglitazone does not improve vascular function in subjects with chronic kidney disease.Insulin resistance in chronic kidney disease.Short-term efficacy and safety of sitagliptin treatment in long-term stable renal recipients with new-onset diabetes after transplantation.
P2860
Q28083882-1AE6D915-4F18-4F27-86D8-B30D70576753Q33241175-C30AA43D-53F4-4842-847C-6A25F698D206Q33727430-F154D135-94DD-4791-8DA5-EA2328D25D5DQ36577073-807B49B9-4AF3-4CD4-8B06-E74037C68188Q37395321-4FAF8E0D-BE64-404A-8231-854AF106FF6BQ37952000-D6AAE7B9-4D85-4FDC-9A7F-FDA348ADB108Q38445269-3B9706A9-3263-47AF-B7BF-586534975776Q38587721-9C0F3AE0-8E5F-4EE7-9CCC-457CE76F7EA3Q39441009-4F68BEA3-A2D6-4B00-BAE1-7437560A08BFQ42008239-D71258AB-C460-4ECE-8718-74A765F9390CQ44983950-D26143DE-33FB-4520-875F-FB4936D008C2Q49859006-C27D52B6-D0AE-4788-9C2A-10D9C9A8061CQ51328144-85C002DF-47DF-4AEA-8C76-5ED5223D60D9
P2860
Short-term treatment with rosiglitazone improves glucose tolerance, insulin sensitivity and endothelial function in renal transplant recipients.
description
2004 nî lūn-bûn
@nan
2004 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Short-term treatment with rosi ...... n renal transplant recipients.
@ast
Short-term treatment with rosi ...... n renal transplant recipients.
@en
type
label
Short-term treatment with rosi ...... n renal transplant recipients.
@ast
Short-term treatment with rosi ...... n renal transplant recipients.
@en
prefLabel
Short-term treatment with rosi ...... n renal transplant recipients.
@ast
Short-term treatment with rosi ...... n renal transplant recipients.
@en
P2093
P2860
P356
P1476
Short-term treatment with rosi ...... n renal transplant recipients.
@en
P2093
Anders Asberg
Anders Hartmann
Cathrine Simonsen
Jøran Hjelmesaeth
Monica Hagen Voytovich
Trond Jenssen
P2860
P304
P356
10.1093/NDT/GFH641
P407
P577
2004-12-22T00:00:00Z